Administration of anti-CD3 antibodies in the treatment of autoimmune diseases

Details for Australian Patent Application No. 2007258694 (hide)

International Classifications

Event Publications

29 January 2009 PCT application entered the National Phase

PCT publication WO2007/145941 Priority application(s): WO2007/145941

8 December 2011 Alteration of Name

The name of the applicant has been altered to Tolerx, Inc.

22 December 2011 Application Accepted

Published as AU-B-2007258694

1 March 2012 Assignment before Grant

Tolerx, Inc. The application has been assigned to Glaxo Group Limited

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.